Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | GAA | P10253 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | ERN1 | O75460 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4962062 | 0.83 | ALDH1A1 (0.46) | MAPTGAALMNARAB9AKDM4E | |
| SCHEMBL91201 | 0.77 | ERN1 (0.61) | MAPTGAALMNASMN1; SMN2RAB9A | |
| SCHEMBL29356117 | 0.76 | ERN1 (0.60) | MAPTGAALMNASMN1; SMN2RAB9A | |
| SCHEMBL131222 | 0.76 | ERN1 (0.60) | MAPTGAALMNASMN1; SMN2RAB9A | |
| SCHEMBL180459 | 0.76 | ALDH1A1 (0.41) | ALDH1A1HSD11B1 | |
| SCHEMBL29661897 | 0.76 | ALDH1A1 (0.41) | ALDH1A1HSD11B1 | |
| SCHEMBL29418131 | 0.75 | — | — | |
| SCHEMBL50072 | 0.75 | — | — | |
| SCHEMBL8010113 | 0.74 | ALDH1A1 (0.39) | RAB9ANPC1TDP1ALDH1A1HSD11B1 | |
| SCHEMBL5257067 | 0.74 | ALDH1A1 (0.39) | MAPTGAALMNASMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111032714-B | Curable petroleum resin, process for its preparation and its use | 可隆工业株式会社 | 2023-02-17 | — | — | CN | claimed |
| CN-111032714-A | Curable petroleum resin, process for its preparation and its use | 可隆工业株式会社 | 2020-04-17 | — | — | CN | claimed |
| EP-0298733-A1 | Flame-retardant resin composition and laminate manufactured therefrom | HITACHI, LTD. (JP) | 1989-01-11 | — | — | EP | claimed |
| CN-111032714-B | Curable petroleum resin, process for its preparation and its use | 可隆工业株式会社 | 2023-02-17 | — | — | CN | disclosed |
| CN-111032714-A | Curable petroleum resin, process for its preparation and its use | 可隆工业株式会社 | 2020-04-17 | — | — | CN | disclosed |
| US-10258602-B2 | Macrocyclic ghrelin receptor modulators and methods of using the same | OCERA THERAPEUTICS, INC. (US) | 2019-04-16 | — | — | US | disclosed |
| US-20180110824-A1 | Macrocyclic Modulators of the Ghrelin Receptor | OCERA THERAPEUTICS, INC. | 2018-04-26 | — | — | US | disclosed |
| US-20180110824-A1 | Macrocyclic Modulators of the Ghrelin Receptor | OCERA THERAPEUTICS, INC. | 2018-04-26 | — | — | US | disclosed |
| US-9949949-B2 | Macrocyclic ghrelin receptor modulators and methods of using the same | OCERA THERAPEUTICS, INC. (US) | 2018-04-24 | — | — | US | disclosed |
| US-9949949-B2 | Macrocyclic ghrelin receptor modulators and methods of using the same | OCERA THERAPEUTICS, INC. (US) | 2018-04-24 | — | — | US | disclosed |
| EP-2457893-B1 | Intermediates for macrocyclic modulators of the ghrelin receptor | OCERA THERAPEUTICS INC (US) | 2017-08-16 | — | — | EP | disclosed |
| EP-0954966-B1 | Polymeric controlled release compositions | ROHM & HAAS (US) | 2003-06-25 | — | — | EP | disclosed |
| EP-0954966-A1 | Polymeric controlled release compositions | ROHM AND HAAS COMPANY (US) | 1999-11-10 | — | — | EP | disclosed |
| US-5200454-A | Blend of syndiotactic polymer, thermoplastic resin, halogenated polystyrenes and phosphine oxide | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-04-06 | — | — | US | disclosed |
| EP-0150772-B1 | RELEASE SHEET | OJI PAPER COMPANY LIMITED (JP) | 1989-07-12 | — | — | EP | disclosed |
| US-4609589-A | UNDERCOATINGS, ACRYLIC EMULSION, OXIDIZED STARCHES, LAMINATION, METAL FOIL, CROSSLINKING, THERMOSETTING RESINS | OJI PAPER COMPANY, LTD. (JP) | 1986-09-02 | — | — | US | disclosed |
| EP-0150772-A2 | Release sheet | OJI PAPER COMPANY LIMITED (JP) | 1985-08-07 | — | — | EP | disclosed |
| US-4347305-A | NONSILVER PHOTOGRAPHIC COATING OVER SILVER NALIDE EMULSION; POSITIVES; PHOTORESISTS; MASKING; | FUJI PHOTO FILM CO., LTD. (JP) | 1982-08-31 | — | — | US | disclosed |
| US-4268609-A | Process for preparing photosensitive lithographic printing plate precursor | FUJI PHOTO FILM CO., LTD. (JP) | 1981-05-19 | — | — | US | disclosed |
| US-4115128-A | Positive image forming radiation sensitive compositions containing diazide compound and organic cyclic anhydride | FUJI PHOTO FILM CO., LTD. (JP) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180110824-A1 | Macrocyclic Modulators of the Ghrelin Receptor | GHSR, GIPR, GHRHR | MAPT 4693/4885GAA 1223/4885LMNA 3873/4885 |
| US-10258602-B2 | Macrocyclic ghrelin receptor modulators and methods of using the same | GHSR, GHRHR, GIPR | MAPT 4766/4885GAA 1016/4885LMNA 3492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.